Heilongjiang Lianshun Biotechnology Co., Ltd. invests 3.7 billion yuan in the Qitaihe pharmaceutical industry project (Phase II)

Thread Content

Heilongjiang Lianshun Biotechnology Co., Ltd. Pharmaceutical Industry Project (Phase II): This project is located in Xinli Village, Zhongxinhe Township, Zijiahe District, Qitaihe City, Heilongjiang Province (Jianghe Integrated Green Intelligent Industrial Park), and it was invested in and constructed by Heilongjiang Lianshun Biotechnology Co., Ltd. A new production line for 250 tons per year of androstenedione will be added, along with a production line for 550 tons per year of 9-hydroxyandrostenedione, a production line for 250 tons per year of BA, a production line for 120 tons per year of A-ring degradation products, a production line for 500 tons per year of ampicillin, a production line for 80 tons per year of vancomycin hydrochloride, and a production line for 2000 tons per year of silicone defoamers. There will also be a production line for 2300 t/a of heptamethyldisilazane, a production line for 3000 t/a of phenyl dichlorophosphate, a production line for 2000 t/a of N,N-diethylethyl isothiourea hydrochloride (HE), a production line for 900 t/a of zinc trifluoroacetate, a production line for 2000 t of tylosin tartrate, and a production line for 4000 t/a of erythromycin thiocyanate. Expand one production line for 2,500 t/a of emamectin benzoate, and expand one production line with an annual output of 2,000 tons of abamectin. One existing production line capable of producing 5,000 tons of tylosin tartrate per year will be converted into one production line producing 2,500 tons of tylosin tartrate per year and one production line producing 2,500 tons of tylosin phosphate per year. The total investment for the project is 3.7 billion yuan.